← Back to Search

AR-Combination for Tobacco-Related Cancer

N/A

Waitlist Available

Led By Joanne G Patterson, PhD MPH MSW

Research Sponsored by Ohio State University Comprehensive Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Young adults (age 18-35 years)

Are susceptible to multiple nicotine and tobacco product use (i.e., have used combustible tobacco or e-cigarettes at least once)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up immediately post-exposure to intervention, up to 1 hour

Awards & highlights

Study Summary

This trial seeks to find better ways to communicate the risks of polytobacco use to LGBT young adults, who are more likely to use multiple tobacco products and become nicotine dependent.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

Participants must be between 18 and 35 years old.

Select...

You have tried using cigarettes or e-cigarettes before.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ immediately post-exposure to intervention, up to 1 hour

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~immediately post-exposure to intervention, up to 1 hour

This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately post-exposure to intervention, up to 1 hour for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Behavioral Intentions to Use Tobacco

Message Perceived Effectiveness - Persuasive Potential.

Perceived Effectiveness - Perceived Behavioral Impact

+1 more

Trial Design

7Treatment groups

Experimental Treatment

Group I: RR-SwitchExperimental Treatment1 Intervention

Participants view messages with comparative risk and switch statements

Group II: RR-QuitExperimental Treatment1 Intervention

Participants view messages with comparative risk and quit statements

Group III: RR-CombinationExperimental Treatment1 Intervention

Participants view messages with comparative risk and combination quit+switch statements

Group IV: ControlExperimental Treatment1 Intervention

Participants view FDA regulatory messages

Group V: AR-SwitchExperimental Treatment1 Intervention

Participants view messages with absolute risk and switch statements

Group VI: AR-QuitExperimental Treatment1 Intervention

Participants view messages with absolute risk and quit statements

Group VII: AR-CombinationExperimental Treatment1 Intervention

Participants view messages with absolute risk and combination quit+switch statements

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Ohio State University Comprehensive Cancer CenterLead Sponsor

320 Previous Clinical Trials

287,318 Total Patients Enrolled

National Cancer Institute (NCI)NIH

13,654 Previous Clinical Trials

40,930,304 Total Patients Enrolled

Joanne G Patterson, PhD MPH MSWPrincipal InvestigatorOhio State University Comprehensive Cancer Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants has the medical trial recruited so far?

"Affirmative. According to clinicaltrials.gov the trial, which was first announced on April 2nd 2021, is presently in search of 2418 patients across 1 site."

Answered by AI

Is participation in this trial restricted to those aged 45 and younger?

"The qualifications to join this clinical trial are an age of 18 or higher and not exceeding 35 years old."

Answered by AI

Is this clinical research available to participants at present?

"That is correct. The clinicaltrial.gov portal reveals that this trial, which was first advertised on April 2nd 2021, is still seeking participants for enrollment. 2418 patients need to be recruited from 1 location."

Answered by AI

Do I meet the requirements to join this clinical experiment?

"This clinical trial seeks 2418 young adults (aged 18-35) in the United States who have been exposed to nicotine and tobacco products. To qualify, individuals must possess a diagnosis of tobacco-related carcinoma as well as having used combustible or e-cigarettes at least once."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Evaluating Anti-Tobacco Message Effectiveness Among Lesbian, Gay, Bisexual, and Transgender Young Adults

Joanne Patterson 2021. "Evaluating Anti-Tobacco Message Effectiveness Among Lesbian, Gay, Bisexual, and Transgender Young Adults". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05393869.